Alcon ALC

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.91 (+0.99%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Alcon (ALC)
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $93.03

  • Market Cap

    $46.01 Billion

  • Price-Earnings Ratio

    -53.47

  • Total Outstanding Shares

    494.62 Million Shares

  • Total Employees

    25,599

  • Dividend

    $0.24 Per Share Annually

  • IPO Date

    April 9, 2019

  • Primary Exchange

    New York Stock Exchange

  • Type

    Common Stock

  • Homepage

    https://www.alcon.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

April 1, 2012 to March 31, 2013
MetricValue
Net Cash Flow From Investing Activities$-73.27 Million
Net Cash Flow From Operating Activities$-19.24 Million
Net Cash Flow From Financing Activities$96.67 Million
Net Cash Flow From Investing Activities, Continuing$-73.27 Million
Net Cash Flow$4.16 Million
Net Cash Flow, Continuing$4.16 Million

Income Statement

April 1, 2012 to March 31, 2013
MetricValue
Basic Average Shares$68.91 Million
Other Operating Expenses$252.24 Million
Income Tax Expense/Benefit$-24.19 Million
Income Tax Expense/Benefit, Deferred$-16.12 Million
Operating Expenses$278.87 Million
Basic Earnings Per Share$-1.74

Comprehensive Income

April 1, 2012 to March 31, 2013
MetricValue
Comprehensive Income/Loss Attributable To Parent$-39.86 Million
Comprehensive Income/Loss$-39.99 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$-8.21 Million

Balance Sheet

April 1, 2012 to March 31, 2013
MetricValue
Equity Attributable To Parent$269.67 Million
Current Liabilities$182.23 Million
Accounts Payable$8.03 Million
Current Assets$33.24 Million
Assets$509.22 Million
Equity$269.67 Million

Historical Dividends

Current dividend: $0.24 Per Share Annually
Announcement DatePayment DateRecord DateAmountFrequency
Feb 28, 2024May 16, 2024May 15, 2024$0.24Annually
Mar 2, 2023May 12, 2023May 11, 2023$0.21Annually
Feb 27, 2022May 5, 2022May 4, 2022$0.2Annually
Feb 24, 2021May 6, 2021May 5, 2021$0.1Annually

Recent Headlines From The Web

Latest news, press releases, and media coverage about ALC from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.